$6 pps is over $1 billion in market cap. Not sure why a drug that is right now liekly slotted for 3rd line in europe would be worth $1 billion in market cap given the limited profitability we would be able to realize in Europe alone. Im not saying ARIAD the company is worth less than $6 per share but don't understand why you think iclusig in europe alone would be worth that much.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.